172 related articles for article (PubMed ID: 16325209)
1. COX-2 mediates morphine-induced delayed cardioprotection via an iNOS-dependent mechanism.
Jiang X; Shi E; Nakajima Y; Sato S
Life Sci; 2006 Apr; 78(22):2543-9. PubMed ID: 16325209
[TBL] [Abstract][Full Text] [Related]
2. Cyclooxygenase-1 mediates the final stage of morphine-induced delayed cardioprotection in concert with cyclooxygenase-2.
Jiang X; Shi E; Nakajima Y; Sato S; Ohno K; Yue H
J Am Coll Cardiol; 2005 May; 45(10):1707-15. PubMed ID: 15893191
[TBL] [Abstract][Full Text] [Related]
3. COX-2 and iNOS in opioid-induced delayed cardioprotection in the intact rat.
Patel HH; Hsu AK; Gross GJ
Life Sci; 2004 May; 75(2):129-40. PubMed ID: 15120566
[TBL] [Abstract][Full Text] [Related]
4. [Morphine-induced late cardioprotection: potential role of inducible nitric oxide synthase].
Shi EY; Jiang XJ; Bai H; Nakajima Y
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):891-5. PubMed ID: 15329271
[TBL] [Abstract][Full Text] [Related]
5. Inducible nitric oxide synthase mediates delayed cardioprotection induced by morphine in vivo: evidence from pharmacologic inhibition and gene-knockout mice.
Jiang X; Shi E; Nakajima Y; Sato S
Anesthesiology; 2004 Jul; 101(1):82-8. PubMed ID: 15220775
[TBL] [Abstract][Full Text] [Related]
6. Inducible nitric oxide synthase mediates delayed myocardial protection induced by activation of adenosine A(1) receptors: evidence from gene-knockout mice.
Zhao T; Xi L; Chelliah J; Levasseur JE; Kukreja RC
Circulation; 2000 Aug; 102(8):902-7. PubMed ID: 10952960
[TBL] [Abstract][Full Text] [Related]
7. Cyclooxygenase-2 mediates the cardioprotective effects of the late phase of ischemic preconditioning in conscious rabbits.
Shinmura K; Tang XL; Wang Y; Xuan YT; Liu SQ; Takano H; Bhatnagar A; Bolli R
Proc Natl Acad Sci U S A; 2000 Aug; 97(18):10197-202. PubMed ID: 10963682
[TBL] [Abstract][Full Text] [Related]
8. Atorvastatin-induced cardioprotection is mediated by increasing inducible nitric oxide synthase and consequent S-nitrosylation of cyclooxygenase-2.
Atar S; Ye Y; Lin Y; Freeberg SY; Nishi SP; Rosanio S; Huang MH; Uretsky BF; Perez-Polo JR; Birnbaum Y
Am J Physiol Heart Circ Physiol; 2006 May; 290(5):H1960-8. PubMed ID: 16339820
[TBL] [Abstract][Full Text] [Related]
9. Cardioprotection afforded by inducible nitric oxide synthase gene therapy is mediated by cyclooxygenase-2 via a nuclear factor-kappaB dependent pathway.
Li Q; Guo Y; Tan W; Ou Q; Wu WJ; Sturza D; Dawn B; Hunt G; Cui C; Bolli R
Circulation; 2007 Oct; 116(14):1577-84. PubMed ID: 17785622
[TBL] [Abstract][Full Text] [Related]
10. COX-2-derived prostacyclin mediates opioid-induced late phase of preconditioning in isolated rat hearts.
Shinmura K; Nagai M; Tamaki K; Tani M; Bolli R
Am J Physiol Heart Circ Physiol; 2002 Dec; 283(6):H2534-43. PubMed ID: 12388283
[TBL] [Abstract][Full Text] [Related]
11. Glycolipid RC-552 induces delayed preconditioning-like effect via iNOS-dependent pathway in mice.
Xi L; Salloum F; Tekin D; Jarrett NC; Kukreja RC
Am J Physiol; 1999 Dec; 277(6):H2418-24. PubMed ID: 10600864
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of cyclooxygenase-2 upregulation in late preconditioning.
Xuan YT; Guo Y; Zhu Y; Han H; Langenbach R; Dawn B; Bolli R
J Mol Cell Cardiol; 2003 May; 35(5):525-37. PubMed ID: 12738234
[TBL] [Abstract][Full Text] [Related]
13. Inducible nitric oxide synthase and cyclooxgenase-2 mediate protection of hydrogen peroxide preconditioning against apoptosis induced by oxidative stress in PC12 cells.
Tang XQ; Yu HM; Zhi JL; Cui Y; Tang EH; Feng JQ; Chen PX
Life Sci; 2006 Jul; 79(9):870-6. PubMed ID: 16616209
[TBL] [Abstract][Full Text] [Related]
14. COX-2: an in vivo evidence of its participation in heat stress-induced myocardial preconditioning.
Arnaud C; Joyeux-Faure M; Godin-Ribuot D; Ribuot C
Cardiovasc Res; 2003 Jun; 58(3):582-8. PubMed ID: 12798431
[TBL] [Abstract][Full Text] [Related]
15. Delayed myocardial preconditioning induced by cobalt chloride in the rat: HIF-1α and iNOS involvement.
Belaidi E; Beguin PC; Levy P; Ribuot C; Godin-Ribuot D
Fundam Clin Pharmacol; 2012 Aug; 26(4):454-62. PubMed ID: 21480981
[TBL] [Abstract][Full Text] [Related]
16. IL-6 plays an obligatory role in late preconditioning via JAK-STAT signaling and upregulation of iNOS and COX-2.
Dawn B; Xuan YT; Guo Y; Rezazadeh A; Stein AB; Hunt G; Wu WJ; Tan W; Bolli R
Cardiovasc Res; 2004 Oct; 64(1):61-71. PubMed ID: 15364614
[TBL] [Abstract][Full Text] [Related]
17. Cyclooxygenase-2 mediates ischemic, anesthetic, and pharmacologic preconditioning in vivo.
Alcindor D; Krolikowski JG; Pagel PS; Warltier DC; Kersten JR
Anesthesiology; 2004 Mar; 100(3):547-54. PubMed ID: 15108967
[TBL] [Abstract][Full Text] [Related]
18. Cardioprotection during the final stage of the late phase of ischemic preconditioning is mediated by neuronal NO synthase in concert with cyclooxygenase-2.
Wang Y; Kodani E; Wang J; Zhang SX; Takano H; Tang XL; Bolli R
Circ Res; 2004 Jul; 95(1):84-91. PubMed ID: 15166094
[TBL] [Abstract][Full Text] [Related]
19. Role of inducible nitric oxide synthase in pharmacological "preconditioning" with monophosphoryl lipid A.
Zhao L; Weber PA; Smith JR; Comerford ML; Elliott GT
J Mol Cell Cardiol; 1997 Jun; 29(6):1567-76. PubMed ID: 9220342
[TBL] [Abstract][Full Text] [Related]
20. Gene therapy with inducible nitric oxide synthase protects against myocardial infarction via a cyclooxygenase-2-dependent mechanism.
Li Q; Guo Y; Xuan YT; Lowenstein CJ; Stevenson SC; Prabhu SD; Wu WJ; Zhu Y; Bolli R
Circ Res; 2003 Apr; 92(7):741-8. PubMed ID: 12702642
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
